195 related articles for article (PubMed ID: 16988624)
1. [Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research].
Desjardins L; Levy-Gabriel C; Lumbroso-Lerouic L; Sastre X; Dendale R; Couturier J; Piperno-Neumann S; Dorval T; Mariani P; Salmon R; Plancher C; Asselain B
J Fr Ophtalmol; 2006 Sep; 29(7):741-9. PubMed ID: 16988624
[TBL] [Abstract][Full Text] [Related]
2. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
4. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
[TBL] [Abstract][Full Text] [Related]
5. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
6. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
7. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up.
Midena E; Bonaldi L; Parrozzani R; Radin PP; Boccassini B; Vujosevic S
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):609-14. PubMed ID: 17934749
[TBL] [Abstract][Full Text] [Related]
8. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of monosomy 3 in uveal melanoma.
Prescher G; Bornfeld N; Hirche H; Horsthemke B; Jöckel KH; Becher R
Lancet; 1996 May; 347(9010):1222-5. PubMed ID: 8622452
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 3 is a valid marker for prognostic testing of biopsy material from uveal melanoma later treated by brachytherapy.
Le Guin CHD; Metz KA; Lehmann N; Kreis SH; Bornfeld N; Rudolf Lohmann D; Zeschnigk M
Biomarkers; 2019 Mar; 24(2):134-140. PubMed ID: 30265160
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
13. [Results of treating uveal melanoma with proton beam radiation: 10-year follow-up].
Hamrouni Z; Levy C; Lumbroso L; D'Hermies F; Frau E; Mazal A; Delacroix S; Nauraye C; Dendale R; Schlienger P; Desjardins L
J Fr Ophtalmol; 2005 Oct; 28(8):833-9. PubMed ID: 16249762
[TBL] [Abstract][Full Text] [Related]
14. Developments in the management of uveal melanoma.
Damato B
Clin Exp Ophthalmol; 2004 Dec; 32(6):639-47. PubMed ID: 15575836
[TBL] [Abstract][Full Text] [Related]
15. [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].
Gambrelle J; Kodjikian L; Rouberol F; Donate D; Duquesne N; Jean-Louis B; Chauvel P; Gérard JP; Romestaing P; Grange JD
J Fr Ophtalmol; 2004 Jan; 27(1):40-7. PubMed ID: 14968076
[TBL] [Abstract][Full Text] [Related]
16. Translating uveal melanoma cytogenetics into clinical care.
Damato B; Coupland SE
Arch Ophthalmol; 2009 Apr; 127(4):423-9. PubMed ID: 19365018
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma - testing of abnormalities of chromosome 3 and 8 in the Czech Republic.
Matuskova V; Hornackova P; Uhmannova R; Zlamalikova L; Liskova K; Uher M; Vlkova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):401-409. PubMed ID: 31544901
[TBL] [Abstract][Full Text] [Related]
18. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture.
Shields JA; Shields CL
Ophthalmology; 2015 Feb; 122(2):414-28. PubMed ID: 25439609
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation.
Cohen VM; Carter MJ; Kemeny A; Radatz M; Rennie IG
Acta Ophthalmol Scand; 2003 Aug; 81(4):383-8. PubMed ID: 12859266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
